IL10 and escherichia coli infection: Succinate- and itaconate-treated BMDMs display decreased secretion of anti-inflammatory IL-10 in response to E. coli infection, compared to untreated BMDMs, while IL-10 secretion in lactate-treated BMDMs remain indifferent (Figure 4C).